TABLE 3.
Pathologies treated | PANDEMIC‐group (Feb‐Apr, 2020) | CONTROL‐group (Feb‐Apr, 2019) |
---|---|---|
Benign tumors | 5 (20.8%) | 12 (19.7%) |
Cerebrospinal fluid leak | 2 (8.3%) | 2 (3.3%) |
Epistaxis | 2 (8.3%) | 3 (4.9%) |
Functional diseases | 1 (4.2%) | 5 (8.2%) |
Inflammatory diseases | 3 (12.5%) | 28 (45.9%) |
Malignant tumors | 11 (45.8%) | 11 (18.0%) |
Total | 24 (100.0%) | 61 (100.0%) |